US 12,133,934 B2
Intravascular devices
Hancun Chen, San Ramon, CA (US); Andrew S. Lee, San Jose, CA (US); and Brent Gerberding, San Jose, CA (US)
Assigned to Stryker Corporation, Kalamazoo, MI (US); and Stryker European Holdings, LLC, Carrigtwohill (IE)
Filed by STRYKER CORPORATION, Kalamazoo, MI (US); and STRYKER EUROPEAN OPERATIONS LIMITED, Carrigtwohill (IE)
Filed on May 11, 2023, as Appl. No. 18/315,502.
Application 18/315,502 is a continuation of application No. 18/176,435, filed on Feb. 28, 2023.
Application 18/176,435 is a continuation of application No. 16/872,124, filed on May 11, 2020, granted, now 11,612,678, issued on Mar. 28, 2023.
Application 16/872,124 is a continuation in part of application No. 16/567,845, filed on Sep. 11, 2019, granted, now 11,484,629, issued on Nov. 1, 2022.
Prior Publication US 2023/0277733 A1, Sep. 7, 2023
Int. Cl. A61K 31/02 (2006.01); A61L 31/02 (2006.01); A61L 31/14 (2006.01); C22C 5/04 (2006.01); A61B 17/12 (2006.01); A61F 2/01 (2006.01); A61F 2/06 (2013.01); A61F 2/90 (2013.01); A61F 2/95 (2013.01); C22C 27/04 (2006.01)
CPC A61L 31/022 (2013.01) [A61L 31/14 (2013.01); A61B 17/1214 (2013.01); A61F 2002/016 (2013.01); A61F 2002/068 (2013.01); A61F 2/90 (2013.01); A61F 2/95 (2013.01); C22C 5/04 (2013.01); C22C 27/04 (2013.01)] 15 Claims
OG exemplary drawing
 
1. An implantable medical device, comprising:
an elongate member made from a material, the material comprising an alloy that includes Platinum (Pt), Tungsten (W), and Zirconium (Zr);
wherein a percentage of the Tungsten (W) in the alloy is equal to or greater than 10% by weight;
wherein a percentage of the Platinum (Pt) and Tungsten (W) in the alloy is at least 95% by weight, and wherein a percentage of the Zirconium (Zr) in the alloy is 5% or less by weight.